WaferGen Q4 Revenues Rise 55 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems reported after the close of the market on Thursday a 55 percent jump in its fourth quarter revenues.

For the three months ended Dec. 31, 2013, total revenues reached $490,465, up from $316,177 in the prior-year fourth quarter. Product revenues increased to $365,465, compared to $316,177 a year ago, while license and royalty revenues in Q4 2013 were $125,000, compared to zero a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.